NEW YORK (
) hit a new 52-week high Tuesday as it traded at $31.88 compared with its previous 52-Week high of $31.80. Centene is changing hands at $31.84 with 41,107 shares traded as of 10:11 a.m. ET. Average volume has been 397,100 shares over the past 30 days.
Centene has a market cap of $1.5 billion and is part of the
industry. Shares are up 24.2% year to date as of the close of trading on Monday.
Centene Corporation operates as a multiline healthcare company in the United States. It operates through two segments, Medicaid Managed Care and Specialty Services. The company has a P/E ratio of 17.2, above the average health services industry P/E ratio of 16.5 and above the S&P 500 P/E ratio of 16.2.
- Practice your CNC trading strategies and win cash in our stock game.
TheStreet Ratings rates Centene as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full
52-week high stocks
or get investment ideas from our